Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

PROCEPT BioRobotics Q1 2024 GAAP EPS $(0.51) Beats $(0.55) Estimate, Sales $44.539M Beat $41.577M Estimate

Author: Benzinga Newsdesk | May 01, 2024 10:40am
PROCEPT BioRobotics (NASDAQ:PRCT) reported quarterly losses of $(0.51) per share which beat the analyst consensus estimate of $(0.55) by 7.27 percent. The company reported quarterly sales of $44.539 million which beat the analyst consensus estimate of $41.577 million by 7.12 percent. This is a 82.51 percent increase over sales of $24.404 million the same period last year.

Posted In: PRCT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist